Atlas Trials

Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer

Clinical trial NCT01610869 · COMPLETED

Trial details

NCT number
NCT01610869
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerFallopian Tube Cancer
Start date
2014-08-01
Primary completion
2018-01-11
Enrollment
117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.